• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Classification of 5-HT(1A) receptor agonists and antagonists using GA-SVM method.使用 GA-SVM 方法对 5-HT(1A) 受体激动剂和拮抗剂进行分类。
Acta Pharmacol Sin. 2011 Nov;32(11):1424-30. doi: 10.1038/aps.2011.112. Epub 2011 Oct 3.
2
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.含内酰胺或酰亚胺部分的 1,3-二恶烷类配体:在α1-肾上腺素受体亚型和 5-HT1A 受体上的结构-亲和力/活性关系。
Eur J Med Chem. 2010 Sep;45(9):3740-51. doi: 10.1016/j.ejmech.2010.05.023. Epub 2010 May 15.
3
In vitro assessment of the agonist properties of the novel 5-HT1A receptor ligand, CUMI-101 (MMP), in rat brain tissue.在体评估新型 5-HT1A 受体配体 CUMI-101(MMP)在大鼠脑组织中的激动剂特性。
Nucl Med Biol. 2011 Feb;38(2):273-7. doi: 10.1016/j.nucmedbio.2010.08.003. Epub 2010 Dec 28.
4
Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT(1A) activity. part 3.具有双重 SSRI 和 5-HT(1A) 活性的新型 4-芳基-吡啶并[1,2-c]嘧啶。第 3 部分。
Eur J Med Chem. 2011 Jan;46(1):142-9. doi: 10.1016/j.ejmech.2010.10.026. Epub 2010 Oct 29.
5
Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors.四氢呋喃-环戊酮和环戊醇基配体的合成、生物评价及在肾上腺素能α₁-和血清素 5-HT1A 受体上的对接研究。
J Med Chem. 2012 Jan 12;55(1):23-36. doi: 10.1021/jm200421e. Epub 2011 Dec 22.
6
Bell-shaped agonist activation of 5-HT receptor-coupled Gαi G-proteins: Receptor density-dependent switch in receptor signaling.5-HT 受体偶联 Gαi G 蛋白的钟形激动剂激活:受体信号转导中受体密度依赖性转换。
Cell Signal. 2019 Nov;63:109383. doi: 10.1016/j.cellsig.2019.109383. Epub 2019 Jul 31.
7
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice.5-羟色胺1A受体阻断对小鼠肠道缺血再灌注相关炎症事件的抑制作用
Pharmacol Res. 2014 Mar;81:17-25. doi: 10.1016/j.phrs.2014.02.002. Epub 2014 Feb 16.
8
The 5-HT(1) receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), subtypes.5-HT(1)受体抑制大鼠血管舒张性感觉 CGRP 能神经流出:进一步涉及 5-HT(1F),而不是 5-HT(1A)或 5-HT(1D)亚型。
Eur J Pharmacol. 2011 Jun 1;659(2-3):233-43. doi: 10.1016/j.ejphar.2011.03.035. Epub 2011 Apr 4.
9
Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.发现一种新型 5-HT(3)拮抗剂/5-HT(1A)激动剂 3-氨基-5,6,7,8-四氢-2-{4-[4-(2-喹啉基)哌嗪-1-基]丁基}喹唑啉-4(3H)-酮(TZB-30878),作为一种可口服生物利用的肠易激综合征治疗药物。
J Med Chem. 2010 Nov 11;53(21):7549-63. doi: 10.1021/jm1002292.
10
Mapping of CBV changes in 5-HT(1A) terminal fields by functional MRI in the mouse brain.功能磁共振成像在小鼠脑内 5-HT(1A)受体末端区域的脑血容量变化定位。
Eur Neuropsychopharmacol. 2011 Apr;21(4):344-53. doi: 10.1016/j.euroneuro.2010.06.010. Epub 2010 Jul 24.

引用本文的文献

1
GPCR-A17 MAAP: mapping modulators, agonists, and antagonists to predict the next bioactive target.GPCR-A17 多配体活性分析图谱:绘制调节剂、激动剂和拮抗剂以预测下一个生物活性靶点。
J Cheminform. 2025 Jul 11;17(1):102. doi: 10.1186/s13321-025-01050-z.
2
Leveraging Artificial Intelligence in GPCR Activation Studies: Computational Prediction Methods as Key Drivers of Knowledge.利用人工智能进行 G 蛋白偶联受体激活研究:计算预测方法作为知识的关键驱动力。
Methods Mol Biol. 2025;2870:183-220. doi: 10.1007/978-1-0716-4213-9_10.
3
Curated Database and Preliminary AutoML QSAR Model for 5-HT1A Receptor.5-羟色胺1A受体的精选数据库及初步自动机器学习定量构效关系模型
Pharmaceutics. 2021 Oct 16;13(10):1711. doi: 10.3390/pharmaceutics13101711.

本文引用的文献

1
Using support vector regression coupled with the genetic algorithm for predicting acute toxicity to the fathead minnow.运用支持向量回归并结合遗传算法预测黑头呆鱼的急性毒性。
SAR QSAR Environ Res. 2010 Jul;21(5-6):559-70. doi: 10.1080/1062936X.2010.502300.
2
Synthesis and in vitro binding studies of piperazine-alkyl-naphthamides: impact of homology and sulphonamide/carboxamide bioisosteric replacement on the affinity for 5-HT1A, alpha2A, D4.2, D3 and D2L receptors.哌嗪-烷基-萘酰胺的合成及体外结合研究:同源性和磺酰胺/羧酰胺生物等排体取代对 5-HT1A、alpha2A、D4.2、D3 和 D2L 受体亲和力的影响。
Bioorg Med Chem Lett. 2010 Sep 1;20(17):5199-202. doi: 10.1016/j.bmcl.2010.07.002. Epub 2010 Jul 6.
3
Searching for multi-target antipsychotics: Discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors.寻找多靶抗精神病药物:发现具有口服活性的杂环 N-苯基哌嗪 D2 样和 5-HT1A 受体配体。
Bioorg Med Chem. 2010 Mar 1;18(5):1925-35. doi: 10.1016/j.bmc.2010.01.040. Epub 2010 Jan 25.
4
Novel benzofuran derivatives with dual 5-HT1A receptor and serotonin transporter affinity.具有双重 5-HT1A 受体和 5-羟色胺转运体亲和力的新型苯并呋喃衍生物。
Bioorg Med Chem Lett. 2010 Feb 1;20(3):824-7. doi: 10.1016/j.bmcl.2009.12.093. Epub 2010 Jan 4.
5
Comparative virtual screening and novelty detection for NMDA-GlycineB antagonists.比较虚拟筛选和 NMDA-甘氨酸 B 拮抗剂的新颖性检测。
J Comput Aided Mol Des. 2009 Dec;23(12):869-81. doi: 10.1007/s10822-009-9304-1. Epub 2009 Nov 5.
6
Synthesis and characterization of environment-sensitive fluorescent ligands for human 5-HT1A receptors with 1-arylpiperazine structure.具有1-芳基哌嗪结构的人5-HT1A受体环境敏感型荧光配体的合成与表征
J Med Chem. 2009 Dec 10;52(23):7892-6. doi: 10.1021/jm900706d.
7
Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity: part 2.具有双重 SSRI 和 5-HT1A 活性的新型 4-芳基吡啶并[1,2-c]嘧啶:第 2 部分。
Eur J Med Chem. 2009 Nov;44(11):4702-15. doi: 10.1016/j.ejmech.2009.07.007. Epub 2009 Jul 16.
8
5-HT(1A) receptor function in major depressive disorder.5-羟色胺(1A)受体在重度抑郁症中的功能
Prog Neurobiol. 2009 May;88(1):17-31. doi: 10.1016/j.pneurobio.2009.01.009. Epub 2009 Feb 7.
9
1,3-Dioxolane-based ligands as rigid analogues of naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors.基于1,3 - 二氧戊环的配体作为萘哌地尔的刚性类似物:α1和5 - HT1A受体的结构 - 亲和力/活性关系
ChemMedChem. 2009 Mar;4(3):393-9. doi: 10.1002/cmdc.200800277.
10
(2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenyl-propyl)-amine: a potent and selective 5-HT(1A) receptor agonist.(2,2-二苯基-[1,3]氧硫杂环戊烷-5-基甲基)-(3-苯基丙基)-胺:一种强效且选择性的5-羟色胺(5-HT)1A受体激动剂。
ChemMedChem. 2009 Feb;4(2):196-203. doi: 10.1002/cmdc.200800276.

使用 GA-SVM 方法对 5-HT(1A) 受体激动剂和拮抗剂进行分类。

Classification of 5-HT(1A) receptor agonists and antagonists using GA-SVM method.

机构信息

Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.

出版信息

Acta Pharmacol Sin. 2011 Nov;32(11):1424-30. doi: 10.1038/aps.2011.112. Epub 2011 Oct 3.

DOI:10.1038/aps.2011.112
PMID:21963891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4002729/
Abstract

AIM

To construct a reliable computational model for the classification of agonists and antagonists of 5-HT(1A) receptor.

METHODS

Support vector machine (SVM), a well-known machine learning method, was employed to build a prediction model, and genetic algorithm (GA) was used to select the most relevant descriptors and to optimize two important parameters, C and r of the SVM model. The overall dataset used in this study comprised 284 ligands of the 5-HT(1A) receptor with diverse structures reported in the literatures.

RESULTS

A SVM model was successfully developed that could be used to predict the probability of a ligand being an agonist or antagonist of the 5-HT(1A) receptor. The predictive accuracy for training and test sets was 0.942 and 0.865, respectively. For compounds with probability estimate higher than 0.7, the predictive accuracy of the model for training and test sets was 0.954 and 0.927, respectively. To further validate our model, the receiver operating characteristic (ROC) curve was plotted, and the Area-Under-the-ROC- Curve (AUC) value was calculated to be 0.883 for training set and 0.906 for test set.

CONCLUSION

A reliable SVM model was successfully developed that could effectively distinguish agonists and antagonists among the ligands of the 5-HT(1A) receptor. To our knowledge, this is the first effort for the classification of 5-HT(1A) receptor agonists and antagonists based on a diverse dataset. This method may be used to classify the ligands of other members of the GPCR family.

摘要

目的

构建一个可靠的计算模型,用于对 5-HT(1A) 受体激动剂和拮抗剂进行分类。

方法

支持向量机(SVM)是一种著名的机器学习方法,用于构建预测模型,遗传算法(GA)用于选择最相关的描述符,并优化 SVM 模型的两个重要参数 C 和 r。本研究使用的总体数据集包括 284 种文献报道的具有不同结构的 5-HT(1A) 受体配体。

结果

成功开发了一种 SVM 模型,可用于预测配体成为 5-HT(1A) 受体激动剂或拮抗剂的概率。训练集和测试集的预测准确率分别为 0.942 和 0.865。对于概率估计值高于 0.7 的化合物,模型对训练集和测试集的预测准确率分别为 0.954 和 0.927。为了进一步验证我们的模型,绘制了接收器工作特征(ROC)曲线,并计算出训练集的 AUC 值为 0.883,测试集的 AUC 值为 0.906。

结论

成功开发了一种可靠的 SVM 模型,可有效区分 5-HT(1A) 受体配体中的激动剂和拮抗剂。据我们所知,这是首次基于多样化数据集对 5-HT(1A) 受体激动剂和拮抗剂进行分类的尝试。该方法可用于对 GPCR 家族其他成员的配体进行分类。